Literature DB >> 1615668

Drug company marketing in the groves of academe.

T B Schwartz1.   

Abstract

Keywords:  American Medical Association; Health Care and Public Health

Mesh:

Year:  1992        PMID: 1615668      PMCID: PMC1003367     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  7 in total

1.  All expenses paid, Doctor.

Authors:  Daniel S Greenberg
Journal:  Lancet       Date:  1990 Dec 22-29       Impact factor: 79.321

2.  Drug promotion and scientific exchange. The role of the clinical investigator.

Authors:  D A Kessler
Journal:  N Engl J Med       Date:  1991-07-18       Impact factor: 91.245

3.  Endorsement of "patient promise" program.

Authors:  T B Schwartz
Journal:  N Engl J Med       Date:  1989-05-18       Impact factor: 91.245

4.  Industrial marketing and medical ethics.

Authors:  E M Bricker
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

5.  Doctors and the drug makers.

Authors:  M D Rawlins
Journal:  Lancet       Date:  1984-08-04       Impact factor: 79.321

6.  The tolbutamide Controversy: a personal perspective.

Authors:  T B Schwartz
Journal:  Ann Intern Med       Date:  1971-08       Impact factor: 25.391

7.  Sounding Boards. The support of continuing medical education by pharmaceutical companies.

Authors:  N M Kaplan
Journal:  N Engl J Med       Date:  1979-01-25       Impact factor: 91.245

  7 in total
  1 in total

1.  The relationship between physicians and the pharmaceutical industry: ethical problems with the every-day conflict of interest.

Authors:  Richard L Allman
Journal:  HEC Forum       Date:  2003-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.